| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/04/2009 | EP2029621A2 Blood-brain barrier targeting antibodies |
| 03/04/2009 | EP2029175A2 Fermentation and purification of actinomadura chromoprotein and related species |
| 03/04/2009 | EP2029174A2 Product and process for increasing compactibility of carbohydrates |
| 03/04/2009 | EP2029162A1 Composition for controlling snoring, in the form of a nasal spray |
| 03/04/2009 | EP2029133A1 Compositions comprising at least one naphthoic acid derivative and at least one film-forming agent, methods for preparing same, and uses thereof |
| 03/04/2009 | EP2029120A2 Nanoparticles containing three various ligands for providing immune responses against infectious agents |
| 03/04/2009 | EP2029111A2 Microparticles and methods for production thereof |
| 03/04/2009 | EP2029107A2 Utilization of vinyl acetate sulfonate copolymers as solubilizers for compounds with low solubility in water |
| 03/04/2009 | EP2029106A2 Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof |
| 03/04/2009 | EP1696913B1 Pharmaceutical composition of vinflunine for parenteral administration, preparation method thereof and use of same |
| 03/04/2009 | EP1682185B1 Compositions and methods for treating a posterior segment of an eye |
| 03/04/2009 | EP1635792B1 Stable pharmaceutical compositions of 2-aza-bicyclo¬3.3.0 -octane-3-carboxylic acid derivatives |
| 03/04/2009 | EP1616005B1 Mannosyl(1-2)glycosyl(1-2)glycerate for the stabilisation and preservation of biomaterials |
| 03/04/2009 | EP1599222B1 Stabilized aqueous compositions comprising tissue factor pathway inhibitor (tfpi) or tissue factor pathway inhibitor variant |
| 03/04/2009 | EP1536844B1 Preparation of m(co)3-complexes by solid phase techniques via metal assisted cleavage from the solid support |
| 03/04/2009 | EP1521572B1 Bioerodible film for ophthalmic drug delivery |
| 03/04/2009 | EP1465498B1 Center-filled chewing gum containing calcium |
| 03/04/2009 | EP1458357B1 Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
| 03/04/2009 | EP1454624B1 Antiviral, antibacterial pharmaceutical composition of cantharidic anhydride and method of preparation thereof |
| 03/04/2009 | EP1432738B1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 03/04/2009 | EP1416926A4 Zinc containing compositions for anti-viral use |
| 03/04/2009 | EP1414494B1 Inhibitory antibodies of her3 activity |
| 03/04/2009 | EP1401863B1 Somatostatin-dopamine chimeric analogs |
| 03/04/2009 | EP1379135B1 Formulations comprising entrapped active ingredients and uses thereof |
| 03/04/2009 | EP1259563B1 Method for the preparation of 1-benzotriazolyl carbonate esters of water soluble polymers. |
| 03/04/2009 | EP1255845B1 Modified cytokines for use in cancer therapy |
| 03/04/2009 | EP1146864B1 Ph independent extended release pharmaceutical formulation |
| 03/04/2009 | EP1045861B1 Bispecific targeting moiety comprising an antibody to carcinoembryonic antigen (cea) and the ligand-binding region of the il13 receptor alpha subunit |
| 03/04/2009 | CN201200625Y Hemorrhoid suppository |
| 03/04/2009 | CN101378783A Methods and compositions for expanding T regulatory cells |
| 03/04/2009 | CN101378782A Protein formulations with reduced viscosity and uses thereof |
| 03/04/2009 | CN101378777A Novel vaccine carrier |
| 03/04/2009 | CN101378767A Stabilized lanthanum carbonate compositions |
| 03/04/2009 | CN101378728A A topical composition comprising an antibacterial substance |
| 03/04/2009 | CN101376024A Agent for protecting pig mycoplasma vaccine and promoting absorption as well as production method and use method thereof |
| 03/04/2009 | CN101376023A Vaccine sustained-release agent for birds as well as preparation and inoculation method thereof |
| 03/04/2009 | CN101376022A Medicament composition containing defibrase modified by PEG |
| 03/04/2009 | CN101375869A Slow/controlled release pellet composition containing ginkgo leaf extracts and preparation method thereof |
| 03/04/2009 | CN101375854A Medicinal preparation for treating osteoarthritis |
| 03/04/2009 | CN101375853A Hemorrhoid ointment and preparation method thereof |
| 03/04/2009 | CN101375849A Novel dosage form of sinomenine medicament or hydrochlorate thereof and preparation technique thereof |
| 03/04/2009 | CN101375848A Fluconazole eye gel |
| 03/04/2009 | CN101375846A Ellagic acid supermolecule composition and preparation method |
| 03/04/2009 | CN101375845A Podophyllotoxin external-use formulation prescription for treating pointed condyloma and herpes genitalis, dosage form series and preparation method |
| 03/04/2009 | CN101375843A Compound tranilast orally disintegrating tablet formulation and preparation method thereof |
| 03/04/2009 | CN101375834A Solid dispersion of Ailamode and preparation method thereof and medicament application |
| 03/04/2009 | CN100465214C 纤维素粉末 Cellulose powder |
| 03/04/2009 | CN100465201C A preparation method of water-soluble resin latex in acrylic acid series used for an intestine soluble coating material of medicines |
| 03/04/2009 | CN100464800C A transdermal drug delivery device with coated microprotrusions |
| 03/04/2009 | CN100464786C An ophthalmic composition for contact lens |
| 03/04/2009 | CN100464754C Acarbose medicine compositions and a preparation method thereof |
| 03/04/2009 | CN100464751C Matrine eye drip liquid and a production method thereof |
| 03/04/2009 | CN100464749C 5HT4 partial agonist pharmaceutical compositions |
| 03/04/2009 | CN100464747C A medicine composition with bailobalide |
| 03/04/2009 | CN100464741C An aqueous-alcoholic depigmenting gel with phenolic derivatives and the vitamer A |
| 03/04/2009 | CN100464740C An osmotic pump controlled release tablet of solid dispersion of hydroxy camptothecin and a preparation method thereof |
| 03/04/2009 | CN100464738C A production method of pharmaceutical solid preparation with poorly soluble drugs |
| 03/04/2009 | CN100464737C A medicinal composition of nimustine and a synergist thereof |
| 03/04/2009 | CN100464736C A slow released anticancer injection with both antimetabolite and a synergist thereof |
| 03/04/2009 | CN100464734C A desensitizing anticarious gel and a preparation method thereof |
| 03/04/2009 | CN100464642C Health-care sand for compound palygorskite homing pigeons |
| 03/03/2009 | US7498436 Substituted hydroxyethylamines |
| 03/03/2009 | US7498360 Adminisering prostaglandin into ear |
| 03/03/2009 | US7498321 17β-carbothioate 17α-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 03/03/2009 | US7498312 Compositions containing piperacillin and tazobactam useful for injection |
| 03/03/2009 | US7498309 Containing a suspending agent (oleoyl macrogol glyceride), and a dispersant (silica sol); treating intestinal bowel disease, Crohn's disease, or colitis, or inflammatory conditions resulting from cytoablative treatment or HIV infection. |
| 03/03/2009 | US7498302 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents |
| 03/03/2009 | US7498298 Monomethylvaline compounds capable of conjugation to ligands |
| 03/03/2009 | US7498152 Interferon-alpha polypeptides and conjugates |
| 03/03/2009 | US7498147 Modulating the activity of one or more elements in the complement/lipid pathway |
| 03/03/2009 | US7498038 Chitin microparticles and their medical uses |
| 03/03/2009 | US7498035 conjugates of methoxylpolyethylene glycol-glutamic acid oligopeptide and drug such as antitumor agents, having low toxicity, improved solubility, sustain and/or control release profiles |
| 03/03/2009 | US7498034 Imaging, diagnosis and treatment of disease |
| 03/03/2009 | US7498030 Treatment with anti-ErbB2 antibodies and anti-hormonal compounds |
| 03/03/2009 | US7498020 Medicaments |
| 03/03/2009 | CA2356197C Thin polymer film drug reservoirs |
| 03/03/2009 | CA2324904C Topical hormonal composition with systemic effect |
| 03/03/2009 | CA2314173C Therapeutic uses of gaseous mixtures of helium and oxygen, in particular in the treatment of asthma |
| 03/03/2009 | CA2280089C Compositions and methods for reducing ocular hypertension |
| 02/26/2009 | WO2009026430A2 Liposome formulations of boronic acid compounds |
| 02/26/2009 | WO2009026427A2 Liposome compositions for in vivo administration of boronic acid compounds |
| 02/26/2009 | WO2009026387A1 Poly(ester urethane) urea foams with enhanced mechanical and biological properties |
| 02/26/2009 | WO2009026328A2 Methods of delivery of agents to leukocytes and endothelial cells |
| 02/26/2009 | WO2009026315A2 Use of carbon nanotube for drug delivery |
| 02/26/2009 | WO2009026306A2 Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions |
| 02/26/2009 | WO2009026178A2 High concentration local anesthetic formulations |
| 02/26/2009 | WO2009026158A2 Inflammation-regulating compositions and methods |
| 02/26/2009 | WO2009025957A1 Erythropoietin receptor peptide formulations and uses |
| 02/26/2009 | WO2009025812A2 Apparatus to treat and prevent atrial tachyarrhythmias |
| 02/26/2009 | WO2009025669A1 Polymeric linkers containing pyridyl disulfide moieties |
| 02/26/2009 | WO2009025576A1 Method for producing the micronised powder of encapsulated organic medicinal substance having a slow water solubility |
| 02/26/2009 | WO2009025372A1 Composition containing reduced coenzyme q10, and method for stabilizing the composition |
| 02/26/2009 | WO2009025315A1 Oral preparation for improvement of bioavailability of curcumin |
| 02/26/2009 | WO2009025277A1 Method of producing reduced coenzyme q10 and method of stabilizing the same |
| 02/26/2009 | WO2009025239A1 Novel preparation for external use |
| 02/26/2009 | WO2009024977A2 Saccharide-containing protein conjugates and uses thereof |
| 02/26/2009 | WO2009024771A2 Materials and methods for treating cancers which express folate receptors |
| 02/26/2009 | WO2009024670A2 Hyaluronic acid injectable gel for treating joint degeneration |
| 02/26/2009 | WO2009024636A1 Nanostructured hybrid material comprising nanoparticles of gold, method of preparation and use |
| 02/26/2009 | WO2009024590A2 Antifungal composition |